157 related articles for article (PubMed ID: 24132401)
41. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management.
Braun S; Watzke H; Hasenkam JM; Schwab M; Wolf T; Dovifat C; Völler H
Thromb Haemost; 2007 Feb; 97(2):310-4. PubMed ID: 17264962
[TBL] [Abstract][Full Text] [Related]
42. Assessment of the CoaguChek-XS portable prothrombin time point-of-care analyzer for horses.
Berlin N; Kelmer E; Segev G; Aroch I; Kelmer G
J Vet Diagn Invest; 2019 May; 31(3):448-452. PubMed ID: 30852982
[TBL] [Abstract][Full Text] [Related]
43. Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding.
Murray D; Pennell B; Olson J
Transfusion; 1999 Jan; 39(1):56-62. PubMed ID: 9920167
[TBL] [Abstract][Full Text] [Related]
44. The danger of relying on the APTT and PT in patients on DOAC therapy, a potential patient safety issue.
Adcock DM; Gosselin RC
Int J Lab Hematol; 2017 May; 39 Suppl 1():37-40. PubMed ID: 28447415
[TBL] [Abstract][Full Text] [Related]
45. Assessment of Stability of Prothrombin Time, International Normalized Ratio, and Activated Partial Thromboplastin Time Under Different Storage Conditions in Human Plasma.
Patil P; Sehgal T; Goswami P; Gaur M; Khan M; Pandey S; Datta SK
Cureus; 2022 Jan; 14(1):e21268. PubMed ID: 35178322
[TBL] [Abstract][Full Text] [Related]
46. Variability in international normalized ratio and activated partial thromboplastin time after injury are not explained by coagulation factor deficits.
Stettler GR; Moore EE; Moore HB; Nunns GR; Coleman JR; Colvis A; Ghasabyan A; Cohen MJ; Silliman CC; Banerjee A; Sauaia A
J Trauma Acute Care Surg; 2019 Sep; 87(3):582-589. PubMed ID: 31136528
[TBL] [Abstract][Full Text] [Related]
47. Effects of sugammadex on activated partial thromboplastin time and prothrombin time in healthy subjects.
De Kam PJ; Grobara P; Prohn M; Höppener F; Kluft C; Burggraaf J; Langdon RB; Peeters P
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):227-36. PubMed ID: 24447651
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
Tseng LW; Hughes D; Giger U
Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
[TBL] [Abstract][Full Text] [Related]
49. Point-of-care coagulation testing for assessment of the pharmacodynamic anticoagulant effect of direct oral anticoagulant.
Mani H; Herth N; Kasper A; Wendt T; Schuettfort G; Weil Y; Pfeilschifter W; Linnemann B; Herrmann E; Lindhoff-Last E
Ther Drug Monit; 2014 Oct; 36(5):624-31. PubMed ID: 24577124
[TBL] [Abstract][Full Text] [Related]
50. Assessment of a portable prothrombin time analyzer (CoaguChek-XS) in dogs.
Kelmer E; Segev G; Codner C; Bruchim Y; Klainbart S; Aroch I
J Vet Emerg Crit Care (San Antonio); 2014; 24(4):455-60. PubMed ID: 25039332
[TBL] [Abstract][Full Text] [Related]
51. Bias and uncertainty of the International Normalized Ratio determined with a whole blood point-of-care prothrombin time test device by comparison to a new International Standard for thromboplastin.
van den Besselaar AMHP; van Rijn CJJ; Abdoel CF; Cobbaert CM
Thromb Res; 2021 Jun; 202():1-7. PubMed ID: 33706049
[TBL] [Abstract][Full Text] [Related]
52. The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients.
Lawrie AS; Hills J; Longair I; Green L; Gardiner C; Machin SJ; Cohen H
Thromb Res; 2012 Jul; 130(1):110-4. PubMed ID: 21937093
[TBL] [Abstract][Full Text] [Related]
53. Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
LaPlante KL; Woodmansee S; Mermel LA
Am J Health Syst Pharm; 2012 Aug; 69(16):1405-9. PubMed ID: 22855107
[TBL] [Abstract][Full Text] [Related]
54. [Evaluation of Portable Coagulation Analyzer in Comparison with Conventional Hospital Laboratory Instrument with Stratification of International Normalized Ratios by Therapeutic Upper Limit].
Sasaki K; Sato K; Suzuki M; Kumagai K; Adachi O; Saiki Y
Kyobu Geka; 2016 May; 69(5):341-5. PubMed ID: 27220921
[TBL] [Abstract][Full Text] [Related]
55. Clinical evaluation of whole blood prothrombin time (PT) and international normalized ratio (INR) using a Laser Speckle Rheology sensor.
Tripathi MM; Egawa S; Wirth AG; Tshikudi DM; Van Cott EM; Nadkarni SK
Sci Rep; 2017 Aug; 7(1):9169. PubMed ID: 28835607
[TBL] [Abstract][Full Text] [Related]
56. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
Toulon P; Fischer F; Appert-Flory A; Jambou D
Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
[TBL] [Abstract][Full Text] [Related]
57. The clinical effectiveness and cost-effectiveness of point-of-care tests (CoaguChek system, INRatio2 PT/INR monitor and ProTime Microcoagulation system) for the self-monitoring of the coagulation status of people receiving long-term vitamin K antagonist therapy, compared with standard UK practice: systematic review and economic evaluation.
Sharma P; Scotland G; Cruickshank M; Tassie E; Fraser C; Burton C; Croal B; Ramsay CR; Brazzelli M
Health Technol Assess; 2015 Jun; 19(48):1-172. PubMed ID: 26138549
[TBL] [Abstract][Full Text] [Related]
58. Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults.
Miljic D; Miljic P; Doknic M; Pekic S; Djurovic M; Colovic M; Popovic V
Hormones (Athens); 2006; 5(3):187-91. PubMed ID: 16950752
[TBL] [Abstract][Full Text] [Related]
59. Point-of-care monitoring of vitamin K-antagonists: validation of CoaguChek XS test strips with International Standard thromboplastin.
van den Besselaar AM; Péquériaux NC; Ebben M; van der Feest J; de Jong K; Ganzeboom MB; van Ooijen J; Postema F; Witteveen E; van der Meer FJ
J Clin Pathol; 2012 Nov; 65(11):1031-5. PubMed ID: 22859395
[TBL] [Abstract][Full Text] [Related]
60. Collection of blood specimens by venipuncture for plasma-based coagulation assays: necessity of a discard tube.
Raijmakers MT; Menting CH; Vader HL; van der Graaf F
Am J Clin Pathol; 2010 Feb; 133(2):331-5. PubMed ID: 20093244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
